American International Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,000
| Closed | -$86K | – | 3301 |
|
|
2022
Q1 | $86K | Sell |
18,000
-1,266
| -7% | -$6.05K | ﹤0.01% | 2649 |
|
|
2021
Q4 | $70K | Sell |
19,266
-576
| -3% | -$2.09K | ﹤0.01% | 2856 |
|
|
2021
Q3 | $159K | Sell |
19,842
-472
| -2% | -$3.78K | ﹤0.01% | 2567 |
|
|
2021
Q2 | $230 | Buy |
+20,314
| New | +$230 | ﹤0.01% | 2421 |
|
|
2015
Q3 | – | Sell |
-5
| Closed | -$3.01K | – | 5069 |
|
|
2015
Q2 | $3.01K | Sell |
5
-143
| -97% | -$86.1K | ﹤0.01% | 4835 |
|
|
2015
Q1 | $76.2K | Sell |
148
-308
| -68% | -$159K | ﹤0.01% | 3751 |
|
|
2014
Q4 | $244K | Sell |
456
-64
| -12% | -$34.3K | ﹤0.01% | 2774 |
|
|
2014
Q3 | $780K | Buy |
520
+14
| +3% | +$21K | ﹤0.01% | 1753 |
|
|
2014
Q2 | $692K | Buy |
506
+62
| +14% | +$84.8K | ﹤0.01% | 1890 |
|
|
2014
Q1 | $616K | Sell |
444
-4
| -0.9% | -$5.55K | ﹤0.01% | 1917 |
|
|
2013
Q4 | $446K | Sell |
448
-27
| -6% | -$26.9K | ﹤0.01% | 2116 |
|
|
2013
Q3 | $494K | Buy |
475
+1
| +0.2% | +$1.04K | ﹤0.01% | 1987 |
|
|
2013
Q2 | $516K | Buy |
+474
| New | +$516K | ﹤0.01% | 1833 |
|